Vitasystems GmbH, headquartered in Mannheim, develops, produces and commissions specific software projects and telemedicine systems; its main business comprises development, hosting, maintenance and services. The company is a subsidiary of vitagroup AG and serves within the Health Intelligence Platform (HIP) division as a development and project competence center; specifically it adapted SORMAS and created the NUM CODEX research platform. Key products and solutions are the HIP Clinical Data Repository (HIP CDR), which went into operation at first institutions in early 2024, and HIP EHRbase launched in 2024 in cooperation projects with partners including AWS, Deutsche Telekom and IBM. Main sales markets are domestic, and in fiscal year 2024 the company employed on average 58 employees.
Die Entwicklung, Vertrieb, industrielle Herstellung, Fertigung und Montage von Komponenten, Systemen der Telemedizin.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 723390 (as of 20 November 2026)
| Name | Type | City |
|---|---|---|
| Nils Hellrung | Geschäftsführer(in) | Braunschweig |
| Kamilo Kolarz | Geschäftsführer(in) | Bad Feilnbach |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 723390 (as of 20 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 20.12.2017 | Business Address Change | Gottlieb-Daimler-Str. 8, 68165 Mannheim |
| 11.11.2015 | Company Name Registered | Vitasystems GmbH |
| 11.11.2015 | Registered Seat | Mannheim |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 11.11.2015 | Share Capital Set | — | 26.000 € |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 723390 (as of 20 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €3,936,432 | -€8,823,479 | €89,359,351 | 58 |
| 2024 | €4,067,240 | -€9,905,589 | €81,623,943 | 58 |
| 2023 | €5,246,828 | -€10,670,615 | €72,103,925 | 78 |
| 2022 | €8,608,032 | -€6,613,714 | €62,062,343 | 76 |
| 2021 | €10,058,950 | -€10,727,596 | €56,320,686 | 83 |
| 2020 | €8,880,827 | -€3,155,040 | €51,726,581 | 63 |
| 2019 | ≤ €12M1 | -€4,784,303 | €44,458,904 | 33 |
| 2018 | ≤ €12M1 | -€2,643,913 | €35,218,443 | 10 |
| 2017 | ≤ €12M1 | -€3,489,220 | €28,382,417 | 17 |
| 2016 | ≤ €12M1 | -€4,523,926 | €25,414,575 | 26 |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Source: German Company Register (Unternehmensregister) · Annual accounts
Sign in to download data
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 723390 (as of 20 November 2026)
THERAMetrics GmbH
Essen · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Vimex Sp. z o.o. Branch Office Germany
Neuss · Befristete Überlassung von Arbeitskräften
IME-DC GmbH International Medical Equipment - Diabetes Care
Hof · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.